基于T1 mapping的肝细胞摄取率用于肝纤维化定量评估
回顾性纳入80例慢性肝病患者,比较T1 mapping衍生参数与血清学评分、LSR对肝纤维化的诊断效能。肝细胞摄取率与KHep在各纤维化组间均有显著差异(均p<0.05),肝细胞摄取率区分中度纤维化(AUC 0.788)和肝硬化(AUC 0.795)的效能最高。
要点
- 肝细胞摄取率区分中度纤维化的AUC为0.788(95%CI 0.682-0.893)。
- 肝细胞摄取率区分肝硬化的AUC为0.795(95%CI 0.697-0.894)。
- 肝细胞摄取率与KHep在轻度、中度纤维化和肝硬化组间均存在显著差异(均p<0.05)。
核心结论
- 肝细胞摄取率作为简单、无创的影像生物标志物,在评估肝纤维化和指导临床管理方面显示出较大潜力。
研究设计与样本
- 回顾性研究,纳入2018年4月至2024年5月间接受MRI和肝脏病理评估的慢性肝病患者80例(轻度纤维化24例、中度纤维化30例、肝硬化26例),由增强前后T1 mapping图像衍生T1pre、T1post、ΔT1、T1弛豫时间下降率、肝细胞摄取率、肝细胞摄取指数(KHep),并在肝胆期图像测量肝脾信号强度比(LSR)。
诊断标准与关键数值
- 轻度(S0+S1)与中度(S2+S3)纤维化及肝硬化(S4)分组依据病理评估;肝细胞摄取率区分中度纤维化AUC 0.788(95%CI 0.682-0.893),区分肝硬化AUC 0.795(95%CI 0.697-0.894),均为所有参数中最高;肝细胞摄取率与KHep在轻度、中度纤维化和肝硬化组间均存在显著差异(均p<0.05)。
临床应用与阅片要点
- 作者认为肝细胞摄取率可作为评估肝纤维化、指导临床管理的简单无创影像生物标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the diagnostic potential of T1 mapping-derived parameters for liver fibrosis, offering a quantitative approach to guide treatment strategies.
MATERIALS AND METHODS: In this retrospective study, patients with chronic liver disease who underwent magnetic resonance imaging and pathological evaluation of the liver between April 2018 and May 2024 were included. The pre-contrast (T1pre) and post-contrast (T1post) T1 relaxation times, the difference between T1pre and T1post (ΔT1), reduction rates of T1 relaxation times, hepatocyte uptake ratio, and hepatocyte uptake index (KHep), were derived from pre-contrast and post-contrast T1 mapping images, and the liver-to-spleen signal intensity ratio (LSR) was measured on hepatobiliary phase images. One-way analysis of variance was used to compare differences in parameters across patients with mild (S0 + S1), moderate (S2 + S3) fibrosis, and cirrhosis (S4). Diagnostic performance was evaluated using the area under the receiver operating characteristic curve (AUC).
RESULTS: Eighty participants were enrolled, including 24 with mild fibrosis, 30 with moderate fibrosis, and 26 with cirrhosis. Serological scores (r = 0.361, 0.401), LSR (r = 0.410), and several conventional T1mapping-related parameters (r = 0.261-0.510) showed weaker correlations with liver fibrosis than hepatocyte uptake parameters (r = 0.549, 0.518). Only hepatocyte uptake ratio and KHep were always significantly different in patients with mild, moderate fibrosis, and cirrhosis (all p < 0.05). Among all parameters, the hepatocyte uptake ratio exhibited the highest AUC values for distinguishing moderate fibrosis (0.788, 95% CI: 0.682-0.893) and cirrhosis (0.795, 95% CI: 0.697-0.894).
CONCLUSION: The hepatocyte uptake ratio shows strong potential as a simple, non-invasive imaging biomarker for assessing liver fibrosis and guiding clinical management.
KEY POINTS: Question Hepatocyte uptake ratio calculated using a two-compartment model has good efficiency in assessing liver function, but has not been studied in liver fibrosis. Finding Hepatocyte uptake ratio has the best diagnostic efficiency for liver fibrosis and cirrhosis compared to serological scores, LSR, and conventional T1 mapping parameters. Critical relevance By applying a two-compartment model to exclude the extracellular space's influence on T1-shortening effect, the hepatocyte uptake ratio outperformed serological scores, LSR, and conventional T1 mapping parameters, offering a promising tool for the non-invasive diagnosis of liver fibrosis and cirrhosis.
引用
- Zhang G, Li M, Feng H, et al. Hepatocyte uptake ratio derived from T1 mapping for quantitative assessment of liver fibrosis. Eur Radiol. 2025. PMID: 40736556. doi:10.1007/s00330-025-11842-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。